Trimethoprim is a synthetic antibacterial agent, closely related to the antimalarial agent pyrimethamine. Chemically Trimethoprim is trimethoxybenzylpyrimidine. It has activity against both gram-positive and gram-negative bacteria. Trimethoprim is commonly used systemically for the treatment and prophylaxis of uncomplicated urinary tract infections, for traveler's diarrhea, and, when combined with either sulfamethoxazole or dapsone, for prophylaxis and treatment of Pneumocystis carinii infections. It was originally made available in combination with sulfamethoxazole in 1973, then was approved by the FDA for use as a single agent in 1980. Antibiotics require constant drug level in body for therapeutic effect. This is achieved by taking the drug at regular intervals of time throughout the day and night as prescribed. Trimethoprim is important to take the drug for the full time period as prescribed. Discontinuation of the drug, may result in ineffective treatment.
. It is of Synthetic origin and belongs to Pyrimidine. It belongs to Dihydrofolate reductase inhibitor pharmacological group on the basis of mechanism of action and also classified in Antibiotics pharmacological group.The Molecular Weight of Trimethoprim is 290.30. Its pKa is 7.3.
Oral absorption of Trimethoprim is found to be 96.5% ±1.5. Volume of distribution is found to be 70 - 100 litre and plasma protien binding is 42 - 46 %. Presystemic metabolism is noted to be 0.5% ±0.5 Renal Excretion accounts for 60 - 80 % and plasma half life is 8.6 - 17 hr.
Trimethoprim is known to interact with other drugs, the details of drug interactions is as follows:
Drug Details Severity Onset Management Amantadine Renal clearance of amantadine is decrease by trimethoprim result in increase risk of mental confusion due to increase in serum amantadine levels.
Minor patient shoulb be monitor for side effects related to nervous system on coadministration this cobination. Azathioprine Coadministration increases the risk of bone marrow supression,thrombocytopenia and neutropenia in renal transplant patient. Moderate Close clinical monitoring for hematological adverse effects is recommended during and after therapy. Bendrofluazide Clozapine Colistin (Sulphate & Sulphomethate Na) Cyclosporin A Trimethoprim decreases the efficacy of cyclosporin.Combined use may increase the serum creatinine level. Moderate Closely monitor the renal function of patient and efficacy and safety of both drugs. An alternative antibiotic may be use. Dapsone Digoxin Ganciclovir (Na) Glipizide Hydrochlorothiazide Lamivudine Lamivudine Metformin (HCl) Trimethoprim reduces the excretion of metformin by competing for renal tubular transport results in increased level of metformin may lead to lactic acidosis. Moderate Slowly reduce the dose of metformin. Closely monitor the blood glucose level. Patient should notify to physician if experience signs of lactic acidosis. Methotrexate Coadministration enhance thre risk of severe myelosuppression and megoblastic anemia due to synergistic effect involving folate antagonism. Major Coadministration generally be avoided. If given then close monitoring for hematologic toxicity is recommended. Norgestimate Para Aminobenzoic Acid Should not be used concurrently except on medical advice. Phenytoin (Na) Pyrimethamine Pyrimethamine Rifampicin Silver Sulphadiazine Sulfadoxine Sulphadiazine Sulphamethoxazole Warfarin (Na) Trimethoprim may decrease the metabolism of Warfarin. Moderate Monitor for increased effects of Warfarin if Trimethoprim is initiated/dose increased, and decreased effects if Trimethoprim is discontinued/dose decreased. Zalcitabine Zidovudine
These interactions are sometimes beneficial and sometimes may pose threats to life. Always consult your physician for the change of dose regimen or an alternative drug of choice that may strictly be required.
Interference in Pathology
No data regarding the pathological interferences produced by Trimethoprim is available.
The signs and symptoms that are produced after the acute overdosage of Trimethoprim include Vomiting, Depression, Psychosis, Mania, Facial edema.
Click on the appropriate strength of the dosage form to view its available brands.
Single Ingredient Susp: 80 mg, 40 mg/5ml, Tabs: 160 mg, 300 mg, Multi ingredient
Inj: 160 mg, Susp: 40 mg/5ml, 80 mg/5ml, 160 mg/5ml, Tabs: 40 mg, 80 mg, 160 mg, 400 mg,
Trimethoprim's dosage details are as follows:
300 mg 300 (300) 24 hourly PO For 7-Days
Paedriatic Dosage ( 20 Kg. )
4 mg/kg 4 (4) 12 hourly Oral -
Neonatal Dosage ( 3 Kg. )
4 mg/kg 4 (4) 12 hourly Oral
High Risk Groups
Drug should not be given to Pregnant Mothers, and Geriatrics.
If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.
Warning / Precautions
Trimethoprim should be used with caution in patients with kidney disease, any anemia or any drug allergy. Trimethoprim should be used during pregnancy only if clearly needed. Avoid use during lactation.
powered by Disqus. comments powered by